juxtapid
(lomitapide mesylate)Amryt Pharmaceuticals DAC
Usage: JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments to reduce LDL-C, total cholesterol, apo B, and non-HDL-C in patients with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness are not established for other types of hypercholesterolemia.